[{"Assets_0_Q1_USD":"55330000000.0","CIK":"818686","CommonStockSharesConverted_0_Q1_shares":"1201000000.0","Country":"Israel","EarningsPerShareBasic_1_Q1_USD":"0.06","EarningsPerShareDiluted_1_Q1_USD":"0.06","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"11303387401.0","MinorityInterest_0_Q1_USD":"1057000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"305000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"69000000.0","NetIncomeLoss_1_Q1_USD":"69000000.0","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","ProfitLoss_1_Q1_USD":"25000000.0","RevenuesConverted_1_Q1_USD":"4357000000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"14588000000.0","StockholdersEquity_0_Q1_USD":"13531000000.0","Ticker":"TEVA","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"1096000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"1093000000.0","filed":"20200507","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","period":"20200331","qtrs":"0","uom":"USD"}]